Lingohr Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,139
| Closed | -$537K | – | 63 |
|
|
2023
Q4 | $537K | Hold |
1,139
| – | – | 1.22% | 51 |
|
|
2023
Q3 | $496K | Hold |
1,139
| – | – | 1.29% | 49 |
|
|
2023
Q2 | $506K | Hold |
1,139
| – | – | 1.29% | 49 |
|
|
2023
Q1 | $524K | Buy |
1,139
+200
| +21% | +$95.2K | 1.34% | 38 |
|
|
2022
Q4 | $482K | Hold |
939
| – | – | 1.35% | 19 |
|
|
2022
Q3 | $513K | Hold |
939
| – | – | 1.41% | 10 |
|
|
2022
Q2 | $448K | Hold |
939
| – | – | 1.19% | 41 |
|
|
2022
Q1 | $461K | Sell |
939
-400
| -30% | -$183K | 1.21% | 44 |
|
|
2021
Q4 | $626K | Sell |
1,339
-30
| -2% | -$12.6K | 1.57% | 11 |
|
|
2021
Q3 | $510K | Hold |
1,369
| – | – | 1.36% | 23 |
|
|
2021
Q2 | $523K | Hold |
1,369
| – | – | 1.32% | 20 |
|
|
2021
Q1 | $491K | Buy |
1,369
+205
| +18% | +$65.9K | 1.23% | 18 |
|
|
2020
Q4 | $374K | Sell |
1,164
-13
| -1% | -$3.99K | 1.08% | 43 |
|
|
2020
Q3 | $316K | Hold |
1,177
| – | – | 1.12% | 9 |
|
|
2020
Q2 | $322K | Buy |
1,177
+77
| +7% | +$20.5K | 1.3% | 39 |
|
|
2020
Q1 | $250K | Buy |
+1,100
| New | +$300K | 1.33% | 48 |
|
|
2018
Q2 | – | Sell |
-2,297
| Closed | -$505K | – | 114 |
|
|
2018
Q1 | $505K | Sell |
2,297
-1,300
| -36% | -$305K | 0.32% | 101 |
|
|
2017
Q4 | $809K | Sell |
3,597
-2,137
| -37% | -$455K | 0.43% | 94 |
|
|
2017
Q3 | $1.2M | Sell |
5,734
-3,371
| -37% | -$642K | 0.61% | 58 |
|
|
2017
Q2 | $1.51M | Sell |
9,105
-80
| -0.9% | -$14.4K | 0.87% | 23 |
|
|
2017
Q1 | $1.52M | Sell |
9,185
-1,200
| -12% | -$191K | 0.83% | 22 |
|
|
2016
Q4 | $1.49M | Buy |
10,385
+300
| +3% | +$40.2K | 0.91% | 33 |
|
|
2016
Q3 | $1.26M | Buy |
10,085
+5,781
| +134% | +$746K | 1.14% | 42 |
|
|
2016
Q2 | $565K | Buy |
+4,304
| New | +$589K | 0.57% | 73 |
|
|
2015
Q1 | – | Sell |
-23,527
| Closed | -$2.53M | – | 106 |
|
|
2014
Q4 | $2.53M | Sell |
23,527
-15,727
| -40% | -$1.94M | 0.63% | 67 |
|
|
2014
Q3 | $4.7M | Buy |
39,254
+15,727
| +67% | +$1.8M | 0.68% | 63 |
|
|
2014
Q2 | $2.53M | Sell |
23,527
-11,500
| -33% | -$1.18M | 0.63% | 67 |
|
|
2014
Q1 | $3.49M | Buy |
35,027
+30,100
| +611% | +$2.72M | 0.71% | 58 |
|
|
2013
Q4 | $455K | Sell |
4,927
-29,075
| -86% | -$2.58M | 0.09% | 99 |
|
|
2013
Q3 | $2.84M | Sell |
34,002
-600
| -2% | -$51.4K | 0.48% | 74 |
|
|
2013
Q2 | $2.83M | Buy |
+34,602
| New | +$2.59M | 0.52% | 73 |
|
Other funds holding ELV
Lingohr Asset Management's ELV Position: Q1 2024 in Review
Lingohr Asset Management sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 1,139 shares — an estimated $537K sold.
Lingohr Asset Management first reported a position in ELV in Q2 2013 and held it in 31 quarters. The position peaked at $4.7M in Q3 2014. 1,667 funds tracked by Wall St. Rank hold ELV as of Q1 2024.
- Lingohr Asset Management reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
- Lingohr Asset Management sold 1,139 Elevance Health shares in Q1 2024, an estimated $537K.
- Lingohr Asset Management first reported a position in Elevance Health in Q2 2013 and held it in 31 quarters.
- Lingohr Asset Management's Elevance Health position peaked at $4.7M in Q3 2014.
- 1,667 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.
Based on Lingohr Asset Management's 13F filing for Q1 2024, filed 14 May 2024.